68Ga-DOTATATE PET/CT in Pituitary Carcinoma

被引：6
作者：
Kaya, Gursan [1 ]
Soydas Turan, Basak
Dagdelen, Selcuk
Berker, Mustafa
Tuncel, Murat
机构：
[1] Hacettepe Univ, Fac Med, Dept Nucl Med, Gevher Nesibe Caddesi, TR-06100 Ankara, Turkey
来源：
CLINICAL NUCLEAR MEDICINE | 2021年 / 46卷 / 12期
关键词：
pituitary carcinoma; Ga-68-DOTATATE; PRRT; theranostic; Lu-177-DOTATATE; MANAGEMENT; DIAGNOSIS;
D O I：
10.1097/RLU.0000000000003804
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 47-year-old woman with atypical pituitary adenoma was referred to the neurosurgery department due to recent back pain. She had multiple transsphenoidal surgery, stereotactic body radiation, and 177Lu-DOTATATE therapy. Her spinal MRI showed multiple spinal masses. The patient underwent 68Ga-DOTATATE PET/CT to confirm the metastatic spread of the disease. PET/CT images showed increased uptake at the local recurrent tumor site and spinal metastases confirmed by biopsy to pituitary carcinoma. Our case presents the role of 68Ga-DOTATATE PET/CT in patients with pituitary carcinoma. © 2020 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码：996 / 998
页数：3
相关论文
共 12 条
[1]   The Past, Present, and Future Statuses of Formerly Classified "Atypical Pituitary Adenomas": A Clinicopathological Assessment of 101 Cases in a Cohort of More than 1,000 Pure Endoscopically Treated Patients in Single Center [J].
Bal, Ercan ;
Kulac, Ibrahim ;
Ayhan, Selim ;
Soylemezoglu, Figen ;
Berker, Mustafa .
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2021, 82 :E94-E100
[2]   Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas [J].
Feng, Zize ;
He, Dongsheng ;
Mao, Zhigang ;
Wang, Zongming ;
Zhu, Yonghong ;
Zhang, Xiangsong ;
Wang, Haijun .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (03) :E130-E134
[3]  
Garmes Heraldo Mendes, 2017, Surg Neurol Int, V8, P162, DOI 10.4103/sni.sni_498_16
[4]   The pituitary in nuclear medicine imaging [J].
Iglesias, Pedro ;
Cardona, Jorge ;
Jose Diez, Juan .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 68 :6-12
[5]   Malignant Pituitary Tumours [J].
Kaltsas G.A. ;
Grossman A.B. .
Pituitary, 1998, 1 (1) :69-81
[6]   Clinical review: Diagnosis and management of pituitary carcinomas [J].
Kaltsas, GA ;
Nomikos, P ;
Kontogeorgos, G ;
Buchfelder, M ;
Grossman, AB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :3089-3099
[7]   Aggressive prolactinomas: how to manage? [J].
Lasolle, Helene ;
Ilie, Mirela Diana ;
Raverot, Gerald .
PITUITARY, 2020, 23 (01) :70-77
[8]  
Pernicone PJ, 1997, CANCER, V79, P804, DOI 10.1002/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO
[9]  
2-3
[10]   European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas [J].
Raverot, Gerald ;
Burman, Pia ;
McCormack, Ann ;
Heaney, Anthony ;
Petersenn, Stephan ;
Popovic, Vera ;
Trouillas, Jacqueline ;
Dekkers, Olaf M. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (01) :G1-G24
12